Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells - PubMed (original) (raw)
. 1994 May 1;57(3):406-12.
doi: 10.1002/ijc.2910570319.
Affiliations
- PMID: 8169003
- DOI: 10.1002/ijc.2910570319
Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells
H C Wu et al. Int J Cancer. 1994.
Abstract
A model of human prostate cancer was established to study cellular interaction between prostate cancer and bone stroma in vivo. In this model, subcutaneous co-injection of 2 non-tumorigenic human cell lines--LNCaP, a prostate cancer cell line, and MS, a bone stromal cell-line--into intact adult male mice resulted in formation of carcinomas that secreted prostate-specific antigen (PSA), a clinically useful human serum prostate cancer marker. In castrated hosts, upon cellular interaction with bone fibroblasts, we observed the progression of these tumors from an androgen-dependent (AD) to an androgen-independent state (AI). We derived 4 LNCaP cell sublines from the chimeric LNCaP/MS tumors: the M subline from intact hosts and the C4, C4-2 and C5 sublines from castrated hosts. The LNCaP sublines had chromosomal markers similar to those of the parental LNCaP cells and distinctly different from those of the MS bone stromal cell line. Although the parental and derived cell lines expressed similar steady-state levels of ornithine decarboxylase transcript, the sublines expressed 5- to 10-fold higher basal steady-state levels of PSA transcript than did the parental LNCaP cell line. The LNCaP sublines formed 13- to 26-fold more soft-agar colonies than the parental LNCaP cell line. The sublines became tumorigenic, yielding an incidence of tumors in intact athymic mice of 7-75%. The LNCaP sublines C4 and C5 (but not the parental and M cell line) formed tumors in castrated hosts when co-injected with bone fibroblasts. A second-generation LNCaP subline, C4-2, was derived from a chimeric tumor induced by co-inoculating castrated mouse with C4 cells and MS cells. We found that C4-2 subline was tumorigenic when inoculated into castrated hosts in the absence of inductive fibroblasts. Moreover, C4-2 was the only subline capable of forming soft-agar colonies when cultured in serum-free medium. In comparison with the parental LNCaP cells, the C4-2 subline expressed lower steady-state levels of androgen receptor (AR) protein and mRNA transcript and lost its androgen responsiveness in vitro. Our results suggest that certain genetic traits of prostate cancer cells may be selected or altered through an "adaptive" mechanism that involves cellular interaction with the bone stromal cells.
Similar articles
- LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis.
Thalmann GN, Sikes RA, Wu TT, Degeorges A, Chang SM, Ozen M, Pathak S, Chung LW. Thalmann GN, et al. Prostate. 2000 Jul 1;44(2):91-103 Jul 1;44(2). doi: 10.1002/1097-0045(20000701)44:2<91::aid-pros1>3.0.co;2-l. Prostate. 2000. PMID: 10881018 - Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.
Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, Hopwood VL, Pathak S, von Eschenbach AC, Chung LW. Thalmann GN, et al. Cancer Res. 1994 May 15;54(10):2577-81. Cancer Res. 1994. PMID: 8168083 - Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer.
Thalmann GN, Sikes RA, Chang SM, Johnston DA, von Eschenbach AC, Chung LW. Thalmann GN, et al. J Natl Cancer Inst. 1996 Jun 19;88(12):794-801. doi: 10.1093/jnci/88.12.794. J Natl Cancer Inst. 1996. PMID: 8637045 - Human prostate cancer progression models and therapeutic intervention.
Chung LW, Kao C, Sikes RA, Zhau HE. Chung LW, et al. Hinyokika Kiyo. 1997 Nov;43(11):815-20. Hinyokika Kiyo. 1997. PMID: 9436028 Review. - The role of stromal-epithelial interaction in normal and malignant growth.
Chung LW. Chung LW. Cancer Surv. 1995;23:33-42. Cancer Surv. 1995. PMID: 7621472 Review.
Cited by
- Identification of Novel Steroidal Androgen Receptor Degrading Agents Inspired by Galeterone 3β-Imidazole Carbamate.
Purushottamachar P, Kwegyir-Afful AK, Martin MS, Ramamurthy VP, Ramalingam S, Njar VC. Purushottamachar P, et al. ACS Med Chem Lett. 2016 May 23;7(7):708-13. doi: 10.1021/acsmedchemlett.6b00137. eCollection 2016 Jul 14. ACS Med Chem Lett. 2016. PMID: 27437082 Free PMC article. - Periprostatic adipose tissue inhibits tumor progression by secreting apoptotic factors: A natural barrier induced by the immune response during the early stages of prostate cancer.
Shao IH, Chang TH, Chang YH, Hsieh YH, Sheng TW, Wang LJ, Chien YH, Huang LK, Chu YC, Kan HC, Lin PH, Yu KJ, Hsieh ML, Chuang CK, Wu CT, Hsieh CH, Pang ST. Shao IH, et al. Oncol Lett. 2024 Aug 8;28(4):485. doi: 10.3892/ol.2024.14617. eCollection 2024 Oct. Oncol Lett. 2024. PMID: 39170882 Free PMC article. - Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions.
Li X, Sterling JA, Fan KH, Vessella RL, Shyr Y, Hayward SW, Matrisian LM, Bhowmick NA. Li X, et al. Mol Cancer Res. 2012 Apr;10(4):494-503. doi: 10.1158/1541-7786.MCR-11-0506. Epub 2012 Jan 30. Mol Cancer Res. 2012. PMID: 22290877 Free PMC article. - The ErbB3-binding protein EBP1 modulates lapatinib sensitivity in prostate cancer cells.
Awasthi S, Ezelle H, Hassel BA, Hamburger AW. Awasthi S, et al. Mol Cell Biochem. 2015 Jul;405(1-2):177-86. doi: 10.1007/s11010-015-2409-z. Epub 2015 Apr 17. Mol Cell Biochem. 2015. PMID: 25876877 Free PMC article. - Perlecan, a candidate gene for the CAPB locus, regulates prostate cancer cell growth via the Sonic Hedgehog pathway.
Datta MW, Hernandez AM, Schlicht MJ, Kahler AJ, DeGueme AM, Dhir R, Shah RB, Farach-Carson C, Barrett A, Datta S. Datta MW, et al. Mol Cancer. 2006 Mar 1;5:9. doi: 10.1186/1476-4598-5-9. Mol Cancer. 2006. PMID: 16507112 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous